# The Use of Duloxetine for Cognition Improvement in Individuals With Mild Cognitive Impairment

> **NCT02590874** · PHASE4 · COMPLETED · sponsor: **University of North Texas Health Science Center** · enrollment: 19 (actual)

## Conditions studied

- Mild Cognitive Impairment
- Depression

## Interventions

- **DRUG:** Duloxetine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02590874
- **Lead sponsor:** University of North Texas Health Science Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2017-07
- **Final completion:** 2018-10
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2018-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02590874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02590874, "The Use of Duloxetine for Cognition Improvement in Individuals With Mild Cognitive Impairment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02590874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*